Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
ID: 360928Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360928
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Cancer Intervention and Surveillance Modeling Network (CISNET) through a Notice of Funding Opportunity (NOFO) aimed at collaborative research projects utilizing simulation and modeling techniques for specific cancer types. The primary objective is to develop evidence-based tools that inform efficient strategies for cancer control, focusing on comparative modeling for cancers such as bladder, breast, cervix, colon/rectum, esophagus, gastric, multiple myeloma, lung, prostate, and uterine. This initiative is crucial for enhancing cancer control efforts and improving outcomes in at-risk populations. The NIH plans to allocate approximately $9.438 million in FY 2026 to fund up to eight awards, with applications due by February 11, 2026. Interested applicants can reach out to Natasha Stout at natasha.stout@nih.gov for further information.

    Point(s) of Contact
    natasha.stout@nih.gov
    Files
    Title
    Posted
    RFA-CA-25-032-Full-Announcement.html
    The Department of Health and Human Services is reissuing a Notice of Funding Opportunity (NOFO) for the Cancer Intervention and Surveillance Modeling Network (CISNET) (RFA-CA-25-032). This NOFO, with an application due date of February 11, 2026, seeks applications for collaborative research projects utilizing simulation and other modeling techniques for specific cancer types (bladder, breast, cervix, colon/rectum, esophagus, gastric, multiple myeloma, lung, prostate, and uterine). The primary goal is to generate evidence-based tools to inform decisions on efficient utilization of technologies and strategies for cancer control, ultimately reducing cancer risk, incidence, morbidity, and mortality. The program focuses on comparative modeling, with each application requiring 2-6 independent modeling teams and one coordinating center. Key priority areas include understanding cancer control efforts, evaluating emerging technologies, informing precision treatment, and improving outcomes in at-risk populations. The NCI intends to commit $9.438M in FY 2026 to fund up to eight awards, with a maximum project period of five years. Applications are limited to a single cancer type, must employ a comparative modeling approach, and cannot involve de novo model development or primary data collection. All applicants must adhere to strict submission guidelines, including specific budget allocations for modeling groups and a coordinating center, and must include a “Model Accessibility Plan”.
    Similar Opportunities
    Forecast to Publish a Funding Opportunity Announcement for the Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cancer Intervention and Surveillance Modeling Network (CISNET) under the U01 cooperative agreement mechanism, which will not allow clinical trials. This initiative aims to leverage simulation modeling to enhance the evidence derived from clinical trials, epidemiologic studies, and surveillance data, thereby informing public health research and priorities throughout the cancer continuum. The opportunity is particularly relevant for small businesses with expertise in comparative simulation modeling methods for cancer control, as well as collaborative teams that integrate knowledge from decision modeling, statistics, health economics, epidemiology, computer science, medicine, and public health. Interested applicants should prepare for the application process, with the estimated synopsis posting date set for July 31, 2025, and the application deadline anticipated for November 7, 2025. For further inquiries, potential applicants can contact Dr. Natasha Stout at natasha.stout@nih.gov or by phone at 240-478-8909.
    Notice of Intent to Publish a Funding Opportunity Announcement for Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) initiative, specifically targeting Lung Cancer Screening (LCS). This initiative aims to fund up to three research projects that will develop and test strategies to enhance the delivery and sustainability of high-quality, guideline-concordant lung cancer screening among high-risk populations. The total estimated funding for this program is $2,400,000, with awards structured as Cooperative Agreements under the UG3/UH3 activity code, requiring clinical trials. The NOFO is anticipated to be published in late Summer 2024, with applications due in late Fall 2024, and the estimated award date is set for July 1, 2025. Interested applicants are encouraged to prepare by reviewing related materials and attending a pre-application webinar, details of which will be announced following the NOFO publication.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network (NCTN) - Network Group Operations Centers, which will require a U10 clinical trial. This initiative aims to provide scientific leadership for the development and implementation of multi-disciplinary, multi-institutional clinical trials targeting various cancer types and populations, focusing on late-phase treatment trials and advanced imaging studies. The funding, estimated at $99.3 million, is intended to support the conduct of essential clinical research for adults, adolescents, and children with cancer, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, applicants should prepare their submissions in advance of the anticipated award date of March 1, 2026.
    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a Notice of Funding Opportunity (NOFO) titled "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes" (PAR-23-254). This initiative aims to encourage researchers to conduct innovative analyses of existing datasets, including clinical, genomic, and epidemiological data, to address critical questions related to cancer risk, treatment responses, and health outcomes. By leveraging previously collected data, the program seeks to enhance understanding of cancer-related issues while allowing for a limited generation of new data for validation purposes. Eligible applicants include a wide range of institutions, with funding capped at $350,000 annually for up to five years. Applications will be accepted from October 2023 until June 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Forecast to Publish a Funding Opportunity Announcement for Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the sustained development of informatics technologies for cancer research and management. This initiative seeks applications for the continued operation and enhancement of existing informatics resources that facilitate data acquisition, management, analysis, and dissemination across various aspects of cancer research, including biology, treatment, early detection, and health disparities. The emphasis is on maintaining resources that have demonstrated significant impact on cancer research, with a focus on user engagement and support. While applications are not currently being solicited, potential applicants are encouraged to prepare collaborative projects in anticipation of the NOFO, which is expected to be posted on August 29, 2025, with a closing date for submissions on November 21, 2025. For further inquiries, interested parties can contact Dr. Juli Klemm at juli.klemm@gmail.com or by phone at 202-853-7889.
    Metastasis Research Network (U54 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Metastasis Research Network (U54 Clinical Trial Not Allowed), aimed at advancing research on cancer metastasis through the establishment of specialized centers. Applicants are required to propose a cohesive scientific theme supported by two or three interdisciplinary research projects that utilize integrative system-level approaches to understand the complexities of metastasis, including factors such as early dissemination and cellular responses to therapies. This initiative is crucial for enhancing our understanding of metastasis as a systemic issue across various cancer types, including rare and pediatric cancers. The total estimated funding for this program is $6.8 million, with individual awards capped at $1.7 million, and the application deadline is expected to close on May 15, 2026. For further inquiries, interested parties can contact Joanna M. Watson, Ph.D., at 240-276-6206 or via email at watsonjo@mail.nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for a single-source grant aimed at establishing the NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network. This initiative seeks to partner with private institutions of higher education to conduct large-scale, multi-site clinical trials, focusing on late-phase treatment trials and advanced imaging across various cancer types, while ensuring regulatory oversight in Canada. The funding, estimated at $3.8 million, is intended to support the NCTN's efforts to enhance clinical research for diverse patient populations, with the application due in late February 2025 and the award anticipated by March 1, 2026. Interested applicants should prepare their proposals in advance of the expected NOFO publication in Fall 2024.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.
    Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)." This initiative invites applications aimed at improving the utility of mammalian cancer models, including organoids and tumoroids, to better represent human biology and address translational deficiencies in existing models. The funding seeks to advance cancer research by fostering innovative approaches to validate these models and enhance their clinical relevance, ultimately aiming to improve patient outcomes. Eligible applicants can receive up to $499,000 per year for a maximum of five years, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-281.html.
    Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Modular R01s in Cancer Control and Population Sciences grant, aimed at advancing research in cancer management and outcomes. This funding opportunity supports innovative projects focusing on statistical methods, epidemiology, digital health, and cancer survivorship, with a particular emphasis on addressing significant challenges in cancer research. Eligible applicants include a diverse range of organizations, such as higher education institutions and community-based organizations, with no cost-sharing requirement, and the maximum funding limit is set at $250,000 per year for a project duration of up to five years. Interested parties should note that applications are due starting January 5, 2025, and can find further details by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PA-25-172.html.